Binfan Chen

1.2k total citations
14 papers, 913 citations indexed

About

Binfan Chen is a scholar working on Immunology, Molecular Biology and Biomaterials. According to data from OpenAlex, Binfan Chen has authored 14 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Binfan Chen's work include Immune cells in cancer (7 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Binfan Chen is often cited by papers focused on Immune cells in cancer (7 papers), Nanoparticle-Based Drug Delivery (5 papers) and Nanoplatforms for cancer theranostics (5 papers). Binfan Chen collaborates with scholars based in China, Uzbekistan and Hong Kong. Binfan Chen's co-authors include Yongzhuo Huang, Ang Gao, Haijun Yu, Madiha Saeed, Yaping Li, Huige Peng, Aihua Wu, Wenyuan Zhang, Bo Hou and Jing Gao and has published in prestigious journals such as Nano Letters, Biomaterials and Advanced Functional Materials.

In The Last Decade

Binfan Chen

14 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Binfan Chen China 12 470 362 340 272 209 14 913
Brandon Piel United States 8 415 0.9× 336 0.9× 472 1.4× 409 1.5× 287 1.4× 10 1.2k
Kuo‐Ching Mei United States 18 490 1.0× 281 0.8× 438 1.3× 331 1.2× 171 0.8× 32 1.1k
Huihai Zhong China 16 536 1.1× 245 0.7× 320 0.9× 217 0.8× 134 0.6× 21 887
Cao Dai Phung South Korea 20 509 1.1× 350 1.0× 407 1.2× 296 1.1× 191 0.9× 33 1.0k
Xinghui Si China 19 622 1.3× 470 1.3× 386 1.1× 346 1.3× 259 1.2× 37 1.2k
Yudi Xu China 15 583 1.2× 513 1.4× 380 1.1× 291 1.1× 217 1.0× 35 1.1k
Yuanlei Fu China 9 684 1.5× 407 1.1× 266 0.8× 226 0.8× 245 1.2× 11 949
Aihua Wu China 19 345 0.7× 273 0.8× 570 1.7× 307 1.1× 204 1.0× 37 1.2k
Mengsi Zhan China 16 484 1.0× 203 0.6× 342 1.0× 247 0.9× 95 0.5× 37 869

Countries citing papers authored by Binfan Chen

Since Specialization
Citations

This map shows the geographic impact of Binfan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binfan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binfan Chen more than expected).

Fields of papers citing papers by Binfan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binfan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binfan Chen. The network helps show where Binfan Chen may publish in the future.

Co-authorship network of co-authors of Binfan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Binfan Chen. A scholar is included among the top collaborators of Binfan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binfan Chen. Binfan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Wang, Yonghui, Binfan Chen, Bin Tu, et al.. (2021). Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer. Nanoscale. 14(6). 2304–2315. 11 indexed citations
2.
Wang, Huiyuan, Jian Gao, Yongzhuo Huang, et al.. (2020). Publisher Correction: ‘TRAIL-based gene delivery and therapeutic strategies’ and ‘Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy’. Acta Pharmacologica Sinica. 42(5). 843–843. 4 indexed citations
3.
Deng, Qiangqiang, Qingli Zhang, Binfan Chen, et al.. (2020). Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway. Scientific Reports. 10(1). 22265–22265. 26 indexed citations
4.
Chen, Binfan, Ang Gao, Bin Tu, et al.. (2020). Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery. Biomaterials. 255. 120187–120187. 105 indexed citations
5.
Zhang, Meng, Yonghui Wang, Yang He, et al.. (2020). Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy. Acta Pharmacologica Sinica. 42(9). 1516–1523. 35 indexed citations
6.
Zhao, Pengfei, Weimin Yin, Aihua Wu, et al.. (2020). Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy. Advanced Functional Materials. 30(16). 28 indexed citations
7.
Tu, Bin, Yang He, Binfan Chen, et al.. (2020). Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment. Biomaterials Science. 8(24). 7166–7176. 19 indexed citations
8.
Gao, Ang, Xianli Hu, Madiha Saeed, et al.. (2019). Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy. Acta Pharmacologica Sinica. 40(9). 1129–1137. 97 indexed citations
9.
Gao, Ang, Binfan Chen, Jing Gao, et al.. (2019). Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer. Nano Letters. 20(1). 353–362. 180 indexed citations
10.
Zhao, Pengfei, Weimin Yin, Aihua Wu, et al.. (2017). Dual‐Targeting to Cancer Cells and M2 Macrophages via Biomimetic Delivery of Mannosylated Albumin Nanoparticles for Drug‐Resistant Cancer Therapy. Advanced Functional Materials. 27(44). 138 indexed citations
11.
Li, Dongdong, Meng Zhang, Fan Xu, et al.. (2017). Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation. Acta Pharmaceutica Sinica B. 8(1). 74–84. 80 indexed citations
12.
13.
Kang, Xuejia, Huiyuan Wang, Huige Peng, et al.. (2017). Codelivery of dihydroartemisinin and doxorubicin in mannosylated liposomes for drug-resistant colon cancer therapy. Acta Pharmacologica Sinica. 38(6). 885–896. 86 indexed citations
14.
Peng, Huige, Binfan Chen, Weitong Huang, et al.. (2017). Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat. Nano Letters. 17(12). 7684–7690. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon Piel Breakdown of academic impact, for papers by Kuo‐Ching Mei Breakdown of academic impact, for papers by Huihai Zhong Breakdown of academic impact, for papers by Cao Dai Phung Breakdown of academic impact, for papers by Xinghui Si Breakdown of academic impact, for papers by Yudi Xu Breakdown of academic impact, for papers by Yuanlei Fu Breakdown of academic impact, for papers by Aihua Wu Breakdown of academic impact, for papers by Mengsi Zhan
Rankless by CCL
2026